Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial

The primary aim of this trial was to determine the recommended phase II dose (RP2D) of weekly paclitaxel (wP) administered in combination with oral metronomic cyclophosphamide (OMC).

Source: BMC Cancer - July 31, 2018 Category: Cancer & Oncology Authors: Diane Pannier, Antoine Adenis, Emilie Bogart, Eric Dansin, St éphanie Clisant-Delaine, Emilie Decoupigny, Anne Lesoin, Eric Amela, Sandrine Ducornet, Jean-Pierre Meurant, Marie-Cécile Le Deley and Nicolas Penel Tags: Research article Source Type: research